Your browser doesn't support javascript.
loading
Safety and tolerability of Pau d' Arco (Tabebuia avellanedae) for primary dysmenorrhea: A single-arm, open-label trial on adults ages 18-45.
McClure, C; Bollen, M; Buttolph, L; Stack, E; Langley, B O; Hanes, D; Wright, K M; Tibbitts, D; Bradley, R.
Affiliation
  • McClure C; Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, United States.
  • Bollen M; Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, United States.
  • Buttolph L; Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, United States.
  • Stack E; Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, United States.
  • Langley BO; Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, United States.
  • Hanes D; Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, United States.
  • Wright KM; Oregon Health & Science University, Portland, Oregon, United States.
  • Tibbitts D; Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, United States.
  • Bradley R; Helfgott Research Institute, National University of Natural Medicine, Portland, Oregon, United States.
Adv Integr Med ; 9(3): 159-166, 2022 Sep.
Article in En | MEDLINE | ID: mdl-36960315

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Patient_preference Language: En Journal: Adv Integr Med Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Aspects: Patient_preference Language: En Journal: Adv Integr Med Year: 2022 Document type: Article Affiliation country: